ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,109,184 | -46.4% | 2,269,478 | -5.0% | 0.00% | – |
Q2 2023 | $5,802,140 | -60.3% | 2,387,712 | -5.9% | 0.00% | – |
Q1 2023 | $14,611,981 | -35.8% | 2,536,802 | -0.3% | 0.00% | -100.0% |
Q4 2022 | $22,757,825 | -24.1% | 2,545,618 | +20.7% | 0.00% | 0.0% |
Q3 2022 | $30,003,000 | +11.1% | 2,109,787 | +14.1% | 0.00% | 0.0% |
Q2 2022 | $26,997,000 | -16.5% | 1,849,082 | +14.3% | 0.00% | 0.0% |
Q1 2022 | $32,314,000 | +27.2% | 1,618,107 | +11.4% | 0.00% | 0.0% |
Q4 2021 | $25,403,000 | +159.5% | 1,452,452 | +16.3% | 0.00% | – |
Q3 2021 | $9,788,000 | -23.0% | 1,248,519 | +1.1% | 0.00% | – |
Q2 2021 | $12,711,000 | +98.5% | 1,235,313 | +152.3% | 0.00% | – |
Q1 2021 | $6,404,000 | +66.1% | 489,628 | +78.4% | 0.00% | – |
Q4 2020 | $3,856,000 | +141.9% | 274,462 | +104.7% | 0.00% | – |
Q3 2020 | $1,594,000 | – | 134,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |